Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
4,798,188
-
Share change
-
-6,218,536
-
Total reported value
-
$1,260,341
-
Price per share
-
$0.26
-
Number of holders
-
20
-
Value change
-
-$3,365,473
-
Number of buys
-
5
-
Number of sells
-
15
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q4 2024
As of 31 Dec 2024,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,798,188 shares.
The largest 10 holders included
SAGE RHINO CAPITAL LLC, Rock Springs Capital Management LP, GOLDMAN SACHS GROUP INC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Rubric Capital Management LP, UBS Group AG, HRT FINANCIAL LP, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.